Want to see IN:KIMS full AI Analyst Report?
KIMS Stock Chart & Stats
₹797.25
₹2.60(0.33%)
At close: 4:00 PM EDT
₹797.25
₹2.60(0.33%)
Day’s Range― - ―
52-Week Range₹575.55 - ₹858.15
Previous CloseN/A
Volume392.18K
Average Volume (3M)104.98K
Market Cap
₹322.31B
Enterprise Value₹293.76K
Total Cash (Recent Filing)₹1.74B
Total Debt (Recent Filing)₹31.87B
Price to Earnings (P/E)150.9
Beta0.75
Next Earnings
Nov 06, 2026EPS Estimate
1.77Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.39
Shares Outstanding420,006,470
10 Day Avg. Volume37,179
30 Day Avg. Volume104,978
Financial Highlights & Ratios
PEG Ratio-2.77
Price to Book (P/B)11.07
Price to Sales (P/S)6.37
P/FCF Ratio-22.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.28
Revenue Forecast (FY)₹51.79B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthRevenue has expanded about threefold from 2021 to 2026 and still grew at a mid-teens rate in 2026. This indicates sustained demand and network expansion potential for tertiary and quaternary care, providing a durable base for future scale if profitability recovers.
Diversified Hospital NetworkThe company operates a multi-specialty hospital network spanning inpatient, outpatient, surgery, diagnostics and pharmacy-related services. This integrated offering can deepen patient relationships, diversify revenue sources and support referrals across specialties over the medium term.
Positive Operating Cash FlowOperating cash flow remained positive at about ₹3.13B and exceeded reported net income of about ₹2.41B in 2026. That indicates underlying operations are producing cash before investment spending, although substantial capex still limits overall free cash generation.
Bears Say
Sharp Margin CompressionProfitability weakened materially despite continued top-line growth, with net margin roughly halving and gross margin also declining. Persistent cost pressure, unfavorable case mix or weaker realizations could reduce earnings conversion and constrain internally funded expansion.
Rising LeverageThe sharp increase in debt-to-equity raises financial risk and reduces flexibility as KIMS funds asset growth and expansion. Higher interest and repayment obligations could pressure future earnings and make the business more sensitive to execution or operating setbacks.
Deeply Negative Free Cash FlowSeveral years of negative free cash flow indicate that expansion and capital expenditure requirements substantially exceed internally generated cash. Continued reliance on debt or external funding could increase liquidity risk and limit the company’s ability to absorb weaker operating performance.
Krishna Institute of Medical Sciences Limited News
KIMS FAQ
What was Krishna Institute of Medical Sciences Limited’s price range in the past 12 months?
Krishna Institute of Medical Sciences Limited lowest stock price was ₹575.55 and its highest was ₹858.15 in the past 12 months.
What is Krishna Institute of Medical Sciences Limited’s market cap?
Krishna Institute of Medical Sciences Limited’s market cap is ₹322.31B.
When is Krishna Institute of Medical Sciences Limited’s upcoming earnings report date?
Krishna Institute of Medical Sciences Limited’s upcoming earnings report date is Nov 06, 2026 which is in 62 days.
How were Krishna Institute of Medical Sciences Limited’s earnings last quarter?
Krishna Institute of Medical Sciences Limited released its earnings results on Aug 03, 2026. The company reported ₹1 earnings per share for the quarter, missing the consensus estimate of ₹1.483 by -₹0.483.
Is Krishna Institute of Medical Sciences Limited overvalued?
According to Wall Street analysts Krishna Institute of Medical Sciences Limited’s price is currently Overvalued.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited does not currently pay dividends.
What is Krishna Institute of Medical Sciences Limited’s EPS estimate?
Krishna Institute of Medical Sciences Limited’s EPS estimate is 1.77.
How many shares outstanding does Krishna Institute of Medical Sciences Limited have?
Krishna Institute of Medical Sciences Limited has 420,006,470 shares outstanding.
What happened to Krishna Institute of Medical Sciences Limited’s price movement after its last earnings report?
Krishna Institute of Medical Sciences Limited reported an EPS of ₹1 in its last earnings report, missing expectations of ₹1.483. Following the earnings report the stock price went up 1.964%.
Which hedge fund is a major shareholder of Krishna Institute of Medical Sciences Limited?
Currently, no hedge funds are holding shares in IN:KIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―